{"name": "Pathogenetix",
 "permalink": "pathogenetix",
 "crunchbase_url": "http://www.crunchbase.com/company/pathogenetix",
 "homepage_url": "http://pathogenetix.com/",
 "blog_url": "http://www.pathogenetix.com/GSS-blog/",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1997,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@pathogenetix.com",
 "phone_number": "(781) 937-5550 ",
 "description": "",
 "created_at": "Thu Jan 21 05:25:10 UTC 2010",
 "updated_at": "Tue Apr 30 00:58:55 UTC 2013",
 "overview": "\u003Cp\u003EPathoGenetiX is developing an automated system for the rapid identification of pathogenic bacterial strains using proprietary Genome Sequence Scanning Technology. The company\u0026#8217;s approach, which employs a single reagent set to generate genomic bar codes based on bacterial DNA, can cost-effectively identify thousands of strains in a single test from complex samples in three hours.  PathoGenetiX is developing its GSS platform for use in genomics research, food and product safety testing, and clinical infectious disease diagnostics, with initial commercial introduction into the research market planned for 2012.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       24],
      "assets/images/resized/0007/4248/74248v3-max-150x150.jpg"],
     [[250,
       41],
      "assets/images/resized/0007/4248/74248v3-max-250x250.jpg"],
     [[338,
       56],
      "assets/images/resized/0007/4248/74248v3-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President  \u0026 Chief Executive Officer \u0026 Board Member",
    "person":
     {"first_name": "Anne",
      "last_name": "Merrifield",
      "permalink": "anne-merrifield",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/6811/256811v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/6811/256811v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/6811/256811v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Vice President, Advanced Platform Research",
    "person":
     {"first_name": "Rudolf",
      "last_name": "Gilmanshin",
      "permalink": "rudolf-gilmanshin",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Business Development",
    "person":
     {"first_name": "John",
      "last_name": "W. Czajka",
      "permalink": "john-w-czajka",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/6814/256814v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/6814/256814v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/6814/256814v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Vice President, Engineering and Manufacturing",
    "person":
     {"first_name": "John",
      "last_name": "Harris",
      "permalink": "john-harris-5",
      "image": null}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Tara",
      "last_name": "Butler",
      "permalink": "tara-butler",
      "image": null}},
   {"is_past": false,
    "title": "Board member",
    "person":
     {"first_name": "Gus",
      "last_name": "Lawlor",
      "permalink": "gus-lawlor",
      "image": null}},
   {"is_past": false,
    "title": "Scientific Advisor \u0026 Board Member",
    "person":
     {"first_name": "Donald",
      "last_name": "M. Crothers",
      "permalink": "donald-m-crothers",
      "image": null}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Steve",
      "last_name": "Gullans",
      "permalink": "steve-gullans",
      "image": null}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Enrico",
      "last_name": "Petrillo",
      "permalink": "enrico-petrillo",
      "image": null}},
   {"is_past": true,
    "title": "CEO",
    "person":
     {"first_name": "John",
      "last_name": "J. Canepa",
      "permalink": "john-j-canepa",
      "image":
       {"available_sizes":
         [[[80,
            80],
           "assets/images/resized/0025/6808/256808v1-max-150x150.jpg"],
          [[80,
            80],
           "assets/images/resized/0025/6808/256808v1-max-250x250.jpg"],
          [[80,
            80],
           "assets/images/resized/0025/6808/256808v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$13.8M",
 "funding_rounds":
  [{"round_code": "debt_round",
    "source_url": "http://www.masshightech.com/stories/2010/01/18/daily20-US-Genomics-finds-1M-funding.html",
    "source_description": "U.S. Genomics finds $1M funding",
    "raised_amount": 1000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 1,
    "funded_day": 19,
    "investments":
     []},
   {"round_code": "unattributed",
    "source_url": "http://www.masshightech.com/stories/2010/11/01/daily47-US-Genomics-renames-to-Pathogenetix-raises-13M.html",
    "source_description": "U.S. Genomics renames to Pathogenetix, raises $1.3M",
    "raised_amount": 1300000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 11,
    "funded_day": 5,
    "investments":
     []},
   {"round_code": "b",
    "source_url": "http://pathogenetix.com/index.php?option=com_content\u0026task=view\u0026id=257\u0026Itemid=2",
    "source_description": "PathoGenetiX Inc. completes first close of Series B Financing ... ",
    "raised_amount": 4000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 8,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Excel Venture Management",
         "permalink": "excel-venture-management",
         "image":
          {"available_sizes":
            [[[150,
               17],
              "assets/images/resized/0010/1993/101993v1-max-150x150.jpg"],
             [[250,
               29],
              "assets/images/resized/0010/1993/101993v1-max-250x250.jpg"],
             [[450,
               52],
              "assets/images/resized/0010/1993/101993v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "CB Health Ventures",
         "permalink": "cb-health-ventures",
         "image":
          {"available_sizes":
            [[[150,
               24],
              "assets/images/resized/0007/1428/71428v1-max-150x150.jpg"],
             [[250,
               41],
              "assets/images/resized/0007/1428/71428v1-max-250x250.jpg"],
             [[377,
               62],
              "assets/images/resized/0007/1428/71428v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HealthCare Ventures",
         "permalink": "healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/9268/49268v1-max-150x150.jpg"],
             [[250,
               34],
              "assets/images/resized/0004/9268/49268v1-max-250x250.jpg"],
             [[290,
               40],
              "assets/images/resized/0004/9268/49268v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.masshightech.com/stories/2011/10/31/daily18-PathoGenetix-adds-75M-to-Series-B-funding.html",
    "source_description": "PathoGenetix adds $7.5M to Series B funding",
    "raised_amount": 7500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 11,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Ascension Health Ventures",
         "permalink": "ascension-health-ventures",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0006/8081/68081v1-max-150x150.jpg"],
             [[250,
               100],
              "assets/images/resized/0006/8081/68081v1-max-250x250.jpg"],
             [[294,
               118],
              "assets/images/resized/0006/8081/68081v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Excel Venture Management",
         "permalink": "excel-venture-management",
         "image":
          {"available_sizes":
            [[[150,
               17],
              "assets/images/resized/0010/1993/101993v1-max-150x150.jpg"],
             [[250,
               29],
              "assets/images/resized/0010/1993/101993v1-max-250x250.jpg"],
             [[450,
               52],
              "assets/images/resized/0010/1993/101993v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "CB Health Ventures",
         "permalink": "cb-health-ventures",
         "image":
          {"available_sizes":
            [[[150,
               24],
              "assets/images/resized/0007/1428/71428v1-max-150x150.jpg"],
             [[250,
               41],
              "assets/images/resized/0007/1428/71428v1-max-250x250.jpg"],
             [[377,
               62],
              "assets/images/resized/0007/1428/71428v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HealthCare Ventures",
         "permalink": "healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/9268/49268v1-max-150x150.jpg"],
             [[250,
               34],
              "assets/images/resized/0004/9268/49268v1-max-250x250.jpg"],
             [[290,
               40],
              "assets/images/resized/0004/9268/49268v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "12 Gill Street",
    "address2": "Suite 2150",
    "zip_code": "01801",
    "city": "Woburn",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "U.S. Genomics renames itself to Pathogenetix and raises $1.3M",
    "stoned_year": 2010,
    "stoned_month": 11,
    "stoned_day": 5,
    "source_url": "http://www.masshightech.com/stories/2010/11/01/daily47-US-Genomics-renames-to-Pathogenetix-raises-13M.html",
    "source_text": null,
    "source_description": "Mass High Tech",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Pathogenetix",
      "permalink": "pathogenetix"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        81],
       "assets/images/resized/0007/4247/74247v1-max-150x150.jpg"],
      [[250,
        136],
       "assets/images/resized/0007/4247/74247v1-max-250x250.jpg"],
      [[450,
        245],
       "assets/images/resized/0007/4247/74247v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}